Curavit Clinical Research is a full-service, virtual contract research organization (VCRO), focused on designing and executing digital-first decentralized clinical trials (DCTs). Founded in 2020 by experts with decades of experience in technology and clinical research, Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations without borders, ultimately bringing trials to patients in the cloud. Curavit's digital-first DCTs improve timelines, reduce costs, yield real-world data, and increase patient access for therapies more effective across representative populations.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
11/14/22 | $5,000,000 | Series A |
Clark Golestani Matt Wallach Narrow Gauge Ventures Osage Venture Partners Royal Street Ventures | undisclosed |